In breast cancer, PDL1 mRNA expression measured using an antibody-independent ISH assay was associated with a long recurrence-free survival [36], whereas protein expression measured using IHC with a commercial rabbit polyclonal antibody was associated with a poor survival [39]. This evidence concerns the gene CD274 and breast carcinoma.